
P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Loading shareholding data...
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
Mr. Narsimha Shibroor Kamath | 19 Feb 2025 | 21 Feb 2025 | 3.24 Cr | 23,000 | ₹133.59 | BUY |
Mr. Narsimha Shibroor Kamath | 18 Feb 2025 | 21 Feb 2025 | 3.24 Cr | 77,000 | ₹127.52 | BUY |
Mrs. Vibha Gagan Sharma | 21 Mar 2025 | 24 Mar 2025 | 25.75 L | 25,000 | ₹122.63 | BUY |
Mrs. Vibha Gagan Sharma | 20 Mar 2025 | 24 Mar 2025 | 25.50 L | 75,000 | ₹120.63 | BUY |
Mr. Gagan Harsh Sharma | 21 May 2025 | 23 May 2025 | 78,863 | 37,258 | ₹121.2 | BUY |
Mr. Gagan Harsh Sharma | 20 May 2025 | 23 May 2025 | 41,605 | 41,605 | ₹121.47 | BUY |
Mr. Gagan Harsh Sharma | 22 May 2025 | 26 May 2025 | 83,570 | 4,707 | ₹121.48 | BUY |
Mr. Gagan Harsh Sharma | 10 Jun 2025 | 12 Jun 2025 | 1.32 L | 1,970 | ₹136.73 | BUY |
Mr. Gagan Harsh Sharma | 09 Jun 2025 | 12 Jun 2025 | 1.30 L | 46,657 | ₹136.7 | BUY |
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹241.12 | +₹27.20 | +12.72% |
| R3 | ₹229.68 | +₹15.76 | +7.37% |
| R2 | ₹222.56 | +₹8.64 | +4.04% |
| R1 | ₹218.24 | +₹4.32 | +2.02% |
| PIVOT | ₹211.12 | -2.80 | -1.31% |
| CURRENT | ₹213.92 | - | - |
| S1 | ₹183.92 | -₹30.00 | -14.02% |
| S2 | ₹195.36 | -₹18.56 | -8.68% |
| S3 | ₹199.68 | -₹14.24 | -6.66% |
| S4 | ₹206.80 | -₹7.12 | -3.33% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
Amrutanjan Health Care Ltd |
Bajaj Healthcare Ltd |
Beta Drugs Ltd |
Gufic BioSciences Ltd |
Hikal Ltd |
Indoco Remedies Ltd |
IOL Chemicals & Pharmaceuticals Ltd |
Jagsonpal Pharmaceuticals Ltd |
Lincoln Pharmaceuticals Ltd |
Morepen Laboratories Ltd |
NGL Fine Chem Ltd |
Orchid Pharma Ltd |
RPG Life Sciences Ltd |
Sigachi Industries Ltd |
SMS Pharmaceuticals Ltd |
Solara Active Pharma Sciences Ltd |
Sun Pharmaceutical Industries Ltd |
Syncom Formulations (India) Ltd |
Themis Medicare Ltd |
TTK Healthcare Ltd |
Unichem Laboratories Ltd |

Bliss GVS Pharma Limited is a pharmaceutical company headquartered in Mumbai, India, established in 1984. Their core business centers around the development, manufacture, and marketing of a diverse range of pharmaceutical formulations both domestically within India and internationally through exports.
The company's product portfolio is extensive and encompasses a wide spectrum of dosage forms. This includes capsules, tablets (including effervescent), injections, suspensions, liquids, creams, ointments, gels, eye and ear drops, suppositories, pessaries, transdermal patches, and other topical preparations like lotions, balms, and sprays. They also produce various other healthcare products such as soaps, shampoos, nasal inhalers, and personal care items.
Bliss GVS's therapeutic areas covered are equally broad, reflecting their commitment to providing a comprehensive range of medications. Their offerings include products addressing pain relief (analgesics), digestive issues (antacids, anti-diarrheals, anti-emetics), infections (antibacterials, antifungals, anti-infectives), respiratory ailments (cough syrups, nasal decongestants), cardiovascular conditions, and many other therapeutic categories. This spans anti-diabetic, anti-inflammatory, anti-malarial, anti-helminthic and numerous other therapeutic areas, along with products for specific conditions such as erectile dysfunction, laryngitis, and pharyngitis. Furthermore, they offer health supplements, vitamins, and other over-the-counter (OTC) products.
In addition to their core pharmaceutical offerings, Bliss GVS expands into related health and personal care areas. They provide products like health and nutritional supplements, vitamin supplements, amino acid preparations, iron tonics, insect repellants, moisturizers, and vaginal hygiene products. This diversification demonstrates a strategy to cater to a wider consumer base beyond prescription medications.
102, Hyde Park, Saki-vihar Road, Andheri-East
Mumbai
MAHARASHTRA
IN
Tel: 912242160000
Website:https://www.blissgvs.com/
Group: Pharmaceuticals, Biotechnology & Life Sciences
Sector: Health Care
Industry: Pharmaceuticals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 831
IPO Date: 26/07/2010
Mr. Narsimha Kamath
Chief Executive Officer
Mr. Deepak Sawant
Chief Financial Officer
Ms. Aditi Bhatt
Compliance Officer, Company Secretary
Mr. Gagan Sharma
Managing Director, Executive Director
Ms. Shruti Rao
Whole-Time Director
Ms. Vibha Sharma
Whole-Time Director
Ms. Shilpa Bhatia
Independent Woman Director
Mr. Santosh Parab
Independent Director
Dr. Nandkumar Chodankar
Additional Non-Executive Independent Director
Get answers to the most common questions about Bliss GVS Pharma Ltd stock price, fundamentals, financial metrics, and investment analysis